TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 3880876

Group type: EXPERIMENTAL
Intervention: 150 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 300 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: 600 IU of d, 1 alpha‐tocopherol per day for two months
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Measurement of serum concentrations of estradiol, progesterone, dehydroepiandrosterone sulfate, and testosterone before and after treatment
Number of subjects: 128
Study: 29520956

Group type: EXPERIMENTAL
Intervention: Anti-bacterial soap (NP-S)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Anti-bacterial soap (P-S)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (NP-DW)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (P-DW)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution (2%) (NP-CHX)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Chlorhexidine gluconate solution (2%) (P-CHX)
Number of subjects: 60
Study: 30541621

Group type: EXPERIMENTAL
Intervention: Baby Steps programme (group education programme and mobile web application)
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Baby Steps programme
Number of subjects: 290

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 290
Study: 28078208

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Ziprasidone
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: ITT group analysis for Risperidone
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: ITT group analysis for Olanzapine
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: ITT group analysis for Quetiapine
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: ITT group analysis for Ziprasidone
Number of subjects: 173
Study: 24901365

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring (25 mg) used continuously for 28 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo vaginal ring
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Dapivirine vaginal ring
Number of subjects: 16
Study: 21656252

Group type: EXPERIMENTAL
Intervention: Participatory return-to-work (RTW) program
Number of subjects: 79
Study: 21190965

Group type: EXPERIMENTAL
Intervention: Longlasting insecticidal nets (treated with deltamethrin)
Number of subjects: 12691

Group type: COMPARATOR
Intervention: Control (no nets)
Number of subjects: 12691
Study: 19142539

Group type: EXPERIMENTAL
Intervention: Proposed technique (vaginoscopy using normal saline at 36 degrees C)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Traditional technique (CO2)
Number of subjects: 184

Group type: EXPERIMENTAL
Intervention: Proposed technique
Number of subjects: 184

Group type: COMPARATOR
Intervention: Traditional technique
Number of subjects: 184
Study: 15629415

Group type: EXPERIMENTAL
Intervention: Oxymorphone ER (10 to 110 mg)
Number of subjects: 213

Group type: EXPERIMENTAL
Intervention: Oxycodone CR (20 to 220 mg)
Number of subjects: 213

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 213
Study: 12833472

Group type: EXPERIMENTAL
Intervention: Darbepoetin alfa for the treatment of anemia
Number of subjects: 250

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 250
Study: 10700535

Group type: EXPERIMENTAL
Intervention: Rice and beans based diet for 3 consecutive days
Number of subjects: 35
Study: 8428041

Group type: EXPERIMENTAL
Intervention: Diflorasone diacetate ointment 0.05%
Number of subjects: 44

Group type: COMPARATOR
Intervention: Betamethasone dipropionate ointment 0.05%
Number of subjects: 44
Study: 3619423

Group type: EXPERIMENTAL
Intervention: 200 mg intravenously
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 750 mg orally
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both intravenous and oral administration
Number of subjects: 24
Study: 29187419

Group type: EXPERIMENTAL
Intervention: F1 hybrids, reciprocal crosses, and parental selfs grown in randomized complete block design
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: F1 hybrids, reciprocal crosses, and parental selfs
Number of subjects: 6
Study: 27499456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10mg
Number of subjects: 439

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25mg
Number of subjects: 439
Study: 26503990

Group type: EXPERIMENTAL
Intervention: iPad™ intervention targeting social communication skills
Number of subjects: 54
Study: 23855325

Group type: EXPERIMENTAL
Intervention: Appearance-change instruction (ACI)
Number of subjects: 315

Group type: COMPARATOR
Intervention: No appearance-change instruction (Control)
Number of subjects: 315
Study: 20703578

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN) analysis using routine laboratory data (PT, INR, platelet count, direct bilirubin, AST/ALT, AST/PLT, and age)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Logistic regression model
Number of subjects: 144
Study: 18823772

Group type: EXPERIMENTAL
Intervention: Oligonucleotide sensor using photon upconverting nanoparticles (NaYF(4) doped with Yb(3+) and Er(3+))
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional fluorophore, N,N,N',N'‐tetramethyl‐6‐carboxyrhodamine (TAMRA)
Number of subjects: 0
Study: 17118022

Group type: EXPERIMENTAL
Intervention: Counting chamber method (using uncentrifuged urine)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional sedimentation method
Number of subjects: 0
Study: 15043296

Group type: EXPERIMENTAL
Intervention: Picoprep‐3
Number of subjects: 400

Group type: COMPARATOR
Intervention: Fleet
Number of subjects: 400
Study: 14639176

Group type: EXPERIMENTAL
Intervention: Pressure preset ventilator (PPV)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Volume preset ventilator
Number of subjects: 11
Study: 12167896

Group type: EXPERIMENTAL
Intervention: Fluoridated whitening dentifrice
Number of subjects: 57

Group type: COMPARATOR
Intervention: Fluoridated regular dentifrice
Number of subjects: 57
Study: 8617581

Group type: EXPERIMENTAL
Intervention: Didemnin B at 3.5 mg/m2
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Didemnin B at 6.3 mg/m2
Number of subjects: 32
Study: 2666024

Group type: EXPERIMENTAL
Intervention: Oral beta-carotene (50 mg/day)
Number of subjects: 1805

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 1805
Study: 987254

Group type: EXPERIMENTAL
Intervention: Fusaric acid calcium salt (5.1 mg/Kg to 6.0 mg/Kg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Fusaric acid calcium salt
Number of subjects: 8
Study: 30291602

Group type: EXPERIMENTAL
Intervention: Automated calls coupled with phone-based pharmacist counseling
Number of subjects: 4876

Group type: COMPARATOR
Intervention: Control clinics (propensity-matched cohort)
Number of subjects: 4876
Study: 28489737

Group type: EXPERIMENTAL
Intervention: Oral use of montelukast sodium
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Nasal spray of mometasone furoate
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Oral use of montelukast sodium + nasal spray of mometasone furoate
Number of subjects: 195

Group type: COMPARATOR
Intervention: Control group (A and B)
Number of subjects: 195
Study: 25836732

Group type: EXPERIMENTAL
Intervention: Telepractice delivery of flow phonation voice therapy exercises
Number of subjects: 14

Group type: COMPARATOR
Intervention: In-person delivery of flow phonation voice therapy exercises
Number of subjects: 14
Study: 23095218

Group type: EXPERIMENTAL
Intervention: Psychometric algorithm for identifying MCI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stably impaired classification over 5 years
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inconsistent classification over time
Number of subjects: 0
Study: 21284444

Group type: EXPERIMENTAL
Intervention: Computer-aided digital microscopy
Number of subjects: 14

Group type: COMPARATOR
Intervention: Unaided digital microscopy
Number of subjects: 14
Study: 19482892

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection guided by electrical stimulation plus physiotherapy
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Botulinum toxin injection guided by palpation plus physiotherapy
Number of subjects: 65

Group type: COMPARATOR
Intervention: Physiotherapy only
Number of subjects: 65
Study: 16524346

Group type: EXPERIMENTAL
Intervention: Computer-assisted behavior change program
Number of subjects: 217

Group type: COMPARATOR
Intervention: Computerized health risk assessment
Number of subjects: 217
Study: 12601540

Group type: EXPERIMENTAL
Intervention: Chemotherapy (CT) alone
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy (CTRT)
Number of subjects: 131

Group type: COMPARATOR
Intervention: No salvage therapy (Control)
Number of subjects: 131
Study: 11938859

Group type: EXPERIMENTAL
Intervention: Lumbricus solution applied to wound surface after hemorrhoidectomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lithospermum erythrorhizon medicated gauze (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lumbricus solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lumbricus preparation
Number of subjects: 0
Study: 9086746

Group type: EXPERIMENTAL
Intervention: 0.25% KT‐210
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8278826

Group type: EXPERIMENTAL
Intervention: 8 inch-lbs torque
Number of subjects: 102

Group type: COMPARATOR
Intervention: 6 inch-lbs torque
Number of subjects: 102
Study: 3552843

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK) within 3 hours
Number of subjects: 251
Study: 29334925

Group type: EXPERIMENTAL
Intervention: Blended Learning (BL)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Face-to-Face Learning (F2FL)
Number of subjects: 30
Study: 27431239

Group type: EXPERIMENTAL
Intervention: Multimedia intervention delivered daily from Day 1 to Day 5 via iPad™, comprising information on the goals of care for each day following surgery.
Number of subjects: 240

Group type: COMPARATOR
Intervention: Usual care as determined by care pathways currently in use across the organization.
Number of subjects: 240
Study: 23799825

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI), full-body compression garments (CG), sleep-hygiene recommendations
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cold-water immersion (CWI) and full-body compression garments (CG)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Sleep-hygiene recommendations
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control condition (postsession stretching, no regulation of sleeping patterns)
Number of subjects: 8
Study: 22820584

Group type: EXPERIMENTAL
Intervention: 3D‐CRT
Number of subjects: 71

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 71
Study: 20656223

Group type: EXPERIMENTAL
Intervention: Plug deployed through the coaxial needle just before the needle was removed
Number of subjects: 339

Group type: COMPARATOR
Intervention: Control (no plug)
Number of subjects: 339
Study: 18318927

Group type: EXPERIMENTAL
Intervention: Automated telephone reminder system (ATRS)
Number of subjects: 253
Study: 15790743

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Clearfil Protect Bond
Number of subjects: 24

Group type: COMPARATOR
Intervention: In vivo and in vitro conditions
Number of subjects: 24
Study: 12865917

Group type: EXPERIMENTAL
Intervention: Stopped hormone replacement therapy (HRT)
Number of subjects: 3

Group type: COMPARATOR
Intervention: Continued taking HRT
Number of subjects: 3

Group type: COMPARATOR
Intervention: Not taking HRT
Number of subjects: 3
Study: 10591436

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking (NNS) in preterm infants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-nutritive sucking (NNS) in full-term infants
Number of subjects: 0
Study: 8901801

Group type: EXPERIMENTAL
Intervention: Oat meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Wheat meal
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Corn meal
Number of subjects: 12

Group type: COMPARATOR
Intervention: Fasting trial (Control)
Number of subjects: 12
Study: 1857480

Group type: EXPERIMENTAL
Intervention: Desferrioxamine (DFO) at a dose of 20-30 mg/kg
Number of subjects: 17

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (r‐HuEPO) at a dose of 40 units/kg/dialysis i.v.
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Desferrioxamine (DFO)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Recombinant human erythropoietin (r‐HuEPO)
Number of subjects: 17
Study: 7048921

Group type: EXPERIMENTAL
Intervention: Acyclovir
Number of subjects: 107

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 107
Study: 31250239

Group type: EXPERIMENTAL
Intervention: Interactive ultrasounds at 24, 30, and 34 gestational weeks and a pregnancy diary with prenatal infant mental health consultations (n=46)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Treatment-as-usual (n=44)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Interactive ultrasounds (n=46)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Both groups (n=90)
Number of subjects: 90
Study: 29905904

Group type: EXPERIMENTAL
Intervention: Beta-alanine (6.4 g day-1)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 20
Study: 28707021

Group type: EXPERIMENTAL
Intervention: Trendelenburg positioning before AVR
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Trendelenburg positioning after AVR
Number of subjects: 37
Study: 26099861

Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids (ICS)
Number of subjects: 189
Study: 24931055

Group type: EXPERIMENTAL
Intervention: High frequency of dietary self-monitoring
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: High consistency of dietary self-monitoring
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Comprehensiveness of information recorded
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Adherence to daily caloric intake goals
Number of subjects: 220
Study: 21373868

Group type: COMPARATOR
Intervention: Control
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Tyvek
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Vinyl
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: W (p)
Number of subjects: 8
Study: 19994686

Group type: EXPERIMENTAL
Intervention: Muscular needling combined with scarring moxibustion
Number of subjects: 60

Group type: COMPARATOR
Intervention: Medication group (oral Diclofenac sodium and intramuscular Methotrexate)
Number of subjects: 60
Study: 17466225

Group type: EXPERIMENTAL
Intervention: Revascularization (n = 49)
Number of subjects: 101

Group type: COMPARATOR
Intervention: No revascularization
Number of subjects: 101
Study: 14731164

Group type: COMPARATOR
Intervention: Ritonavir 200 mg bid
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lopinavir 400 mg bid added on day 15
Number of subjects: 12
Study: 11677800

Group type: EXPERIMENTAL
Intervention: Constant load test with individual lactate minimum intensity (CT1) at 83 +/- 32 watts for 30 minutes.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Constant load test with intensity 10% above the LMI (CT2) at 95 +/- 31 watts for 30 minutes.
Number of subjects: 60
Study: 9134405

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 0
Study: 7963907

Group type: EXPERIMENTAL
Intervention: 600 mg rifampin (RMP)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 1200 mg rifampin (RMP)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Single dose of rifampin (RMP)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Two doses of rifampin (RMP)
Number of subjects: 29
Study: 3115136

Group type: EXPERIMENTAL
Intervention: Ro 15-1788 (1 ml = 0.1 mg active drug)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (5% glucose solution)
Number of subjects: 60
Study: 31237377

Group type: EXPERIMENTAL
Intervention: Problem-solving intervention (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care control group (n=50)
Number of subjects: 100
Study: 29424802

Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 26823128

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg) in CC trial
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg) in PC trial
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo in CP trial
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo in PP trial
Number of subjects: 14
Study: 24724878

Group type: EXPERIMENTAL
Intervention: Seeking Safety (SS)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Women's Health Education (WHE)
Number of subjects: 353
Study: 22609980

Group type: EXPERIMENTAL
Intervention: Cryorecanalization procedure
Number of subjects: 40
Study: 20306851

Group type: EXPERIMENTAL
Intervention: Standardized Dermatophagoides pteronyssinus extract (SIT group, n = 89)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Medical treatment (control group, n = 66)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Standardized Dermatophagoides pteronyssinus extract (SIT group)
Number of subjects: 155

Group type: COMPARATOR
Intervention: Medical treatment (control group)
Number of subjects: 155
Study: 18546665

Group type: EXPERIMENTAL
Intervention: Individual-level training group (learned based on spacing, or second-order relations, of the blobs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic-level training group (learned based on the number of constituent blobs)
Number of subjects: 0
Study: 15749459

Group type: EXPERIMENTAL
Intervention: 10‐mg amlodipine tablet formulation
Number of subjects: 36
Study: 12739704

Group type: EXPERIMENTAL
Intervention: Loperamide (8 mg + 4 mg + 4 mg, administered 12 h and 2 h before, and 7 h after the start of the recording)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Loperamide
Number of subjects: 9
Study: 10394526

Group type: EXPERIMENTAL
Intervention: Falcon dishes
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Nunc dishes
Number of subjects: 100
Study: 8703558

Group type: EXPERIMENTAL
Intervention: TA-0910 (10 mg or 20 mg daily)
Number of subjects: 12
Study: 1992318

Group type: EXPERIMENTAL
Intervention: Bjork-Shiley mechanical prosthesis
Number of subjects: 533

Group type: COMPARATOR
Intervention: Porcine prosthesis
Number of subjects: 533
Study: 6336984

Group type: EXPERIMENTAL
Intervention: Vindesine (VDS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Doxorubicin and Cyclophosphamide (D/C)
Number of subjects: 47
Study: 30729947

Group type: EXPERIMENTAL
Intervention: Biodentine containing 2.5% chlorhexidine and 2.5% cetrimide (EXP)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (CNT) with no antibacterial agents
Number of subjects: 15
Study: 29130810

Group type: EXPERIMENTAL
Intervention: Intravenous 1.26% sodium bicarbonate
Number of subjects: 5177

Group type: COMPARATOR
Intervention: Intravenous 0.9% sodium chloride
Number of subjects: 5177

Group type: EXPERIMENTAL
Intervention: Oral acetylcysteine
Number of subjects: 5177

Group type: COMPARATOR
Intervention: Oral placebo
Number of subjects: 5177
Study: 27268282

Group type: EXPERIMENTAL
Intervention: Third intervention strategy (combined approach)
Number of subjects: 0

Group type: COMPARATOR
Intervention: First intervention strategy (availability heuristic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Second intervention strategy (affect heuristic)
Number of subjects: 0
Study: 24444659

Group type: EXPERIMENTAL
Intervention: Transthoracic echocardiographic (TTE) imaging
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RV fractional area change < 25%
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: RV end-diastolic area index of 18 cm²/m²
Number of subjects: 40
Study: 22976492

Group type: EXPERIMENTAL
Intervention: ACH-1625 (monotherapy)
Number of subjects: 36
Study: 20236198

Group type: EXPERIMENTAL
Intervention: Pale sulfonated shale oil (PSSO) cream 4%
Number of subjects: 99

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 99
Study: 17662293

Group type: EXPERIMENTAL
Intervention: Moderate dose of red wine (4.0+/‐0.4 dl)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High dose of red wine (8.1+/‐0.9 dl)
Number of subjects: 22

Group type: COMPARATOR
Intervention: De-alcoholized red wine
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: High dose of red wine
Number of subjects: 22
Study: 15933926

Group type: EXPERIMENTAL
Intervention: 4 l polyethylene glycol (PEG)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: 2 l PEG plus 10 mg Bisacodyl
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: 90 ml sodium phosphate
Number of subjects: 231
Study: 12619669

Group type: EXPERIMENTAL
Intervention: Ingestion of Japanese persimmon (kaki)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ingestion of freeze-dried kaki
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Eating a cookie with equivalent nutritional content to kaki
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soaking finger in ice-cooled water after kaki consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water consumption
Number of subjects: 0
Study: 10554854

Group type: EXPERIMENTAL
Intervention: Intermittent cross-clamp (Group I; n = 13)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Beating-heart on pump without aortic cross-clamp (Group II; n = 12)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Beating-heart without use of extracorporeal circulation (Group III; n = 13)
Number of subjects: 38
Study: 8908380

Group type: EXPERIMENTAL
Intervention: GLP-1 treatment with regular insulin from day 8 to 12 and GLP-1 only at meals on days 13 and 14
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: GLP-1 treatment
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control group (insulin only)
Number of subjects: 12
Study: 1842206

Group type: EXPERIMENTAL
Intervention: Hart modified Ritchie index
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: American Rheumatism Association (ARA) index
Number of subjects: 4

Group type: COMPARATOR
Intervention: Ritchie index
Number of subjects: 4

Group type: COMPARATOR
Intervention: Simplified Lansbury index
Number of subjects: 4